Literature DB >> 14729344

Structure formation in the C terminus of type III collagen guides disulfide cross-linking.

Sergei P Boudko1, Jürgen Engel.   

Abstract

In type III collagen the main triple-helical domain is followed by a disulfide knot and the C-terminal propeptide, which are both essential for nucleation, stabilization and registration of the triple helix. We demonstrate that oxidative inter-chain disulfide bridging does not occur between the knot sequences GlyProCysCysGly of dissociated randomly coiled chains. N-terminal fusion of the obligatory trimeric domain of mini-fibritin is able to direct this process efficiently, demonstrating a folded precursor mechanism in which the thiol groups have to be properly placed for the formation of native disulfide bonds. The natural C-propeptide domain may act in a similar way as the mini-fibritin domain. After disulfide linkage and triple-helix formation the catalyzing mini-fibritin domain was removed by thrombin cleavage. In this way a short but stable triple-helical collagen fragment was expressed in Escherichia coli for structural and functional studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729344     DOI: 10.1016/j.jmb.2003.11.054

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Thermoresponsive self-assembly of nanostructures from a collagen-like peptide-containing diblock copolymer.

Authors:  Tianzhi Luo; Lirong He; Patrick Theato; Kristi L Kiick
Journal:  Macromol Biosci       Date:  2014-11-13       Impact factor: 4.979

2.  The NC2 domain of collagen IX provides chain selection and heterotrimerization.

Authors:  Sergei P Boudko; Keith D Zientek; Jesse Vance; Jessica L Hacker; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

3.  The coiled-coil domain structure of the Sin Nombre virus nucleocapsid protein.

Authors:  Sergei P Boudko; Richard J Kuhn; Michael G Rossmann
Journal:  J Mol Biol       Date:  2006-12-23       Impact factor: 5.469

4.  Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate Nanovesicles for Targeted Drug Delivery to Collagen-Containing Matrices.

Authors:  Tianzhi Luo; Michael A David; Lucas C Dunshee; Rebecca A Scott; Morgan A Urello; Christopher Price; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2017-08-01       Impact factor: 6.988

5.  The heterozygous disproportionate micromelia (dmm) mouse: morphological changes in fetal cartilage precede postnatal dwarfism and compared with lethal homozygotes can explain the mild phenotype.

Authors:  Robert E Seegmiller; Brandon D Bomsta; Laura C Bridgewater; Cindy M Niederhauser; Carolina Montaño; Sterling Sudweeks; David R Eyre; Russell J Fernandes
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

6.  The cysteine-rich region of type VII collagen is a cystine knot with a new topology.

Authors:  Henrik Wegener; Hauke Paulsen; Karsten Seeger
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

7.  Trimerization and triple helix stabilization of the collagen XIX NC2 domain.

Authors:  Sergei P Boudko; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

8.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

9.  Collagen triple-helix formation in all-trans chains proceeds by a nucleation/growth mechanism with a purely entropic barrier.

Authors:  Annett Bachmann; Thomas Kiefhaber; Sergei Boudko; Jürgen Engel; Hans Peter Bächinger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

10.  Crystal structure of human collagen XVIII trimerization domain: A novel collagen trimerization Fold.

Authors:  Sergei P Boudko; Takako Sasaki; Jürgen Engel; Thomas F Lerch; Jay Nix; Michael S Chapman; Hans Peter Bächinger
Journal:  J Mol Biol       Date:  2009-07-23       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.